nitrobenzene has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Du, Y; Gao, Z; Li, Q; Li, R; Lv, H; Shen, J; Shi, X; Wang, T; Zhang, L | 1 |
1 other study(ies) available for nitrobenzene and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
The discovery of a novel series of potential ERRĪ± inverse agonists based on p-nitrobenzenesulfonamide template for triple-negative breast cancer
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; ERRalpha Estrogen-Related Receptor; Female; Humans; Molecular Docking Simulation; Molecular Structure; Nitrobenzenes; Receptors, Estrogen; Structure-Activity Relationship; Sulfonamides; Triple Negative Breast Neoplasms | 2022 |